Free National NPI Number Registry

Mark G Kris

Home > Mark G Kris

 

NPI Number Detailed Information

Provider Information:

Name: Mark G Kris
Gender: M
Provider License Number If Given: 134739

NPI Information:

NPI: 1174594113
Entity Type
(Individual or Organization):
1-ind
Enumeration Date: 1/29/2006

Last Update Date: 7/8/2007

Reputation Report:

Provider Business Mailing Address:

Address: 633 3RD AVE BOX 3
New York, NY 10017
Phone Number:
Fax Number:

Provider Business Practice Location Address:

Address: 1275 YORK AVE
New York, NY 10021
Phone Number: 6462273813
Fax Number:

Provider Taxonomy:

Primary: 207RX0202X
Secondary (if any):
State: NY

Top Doctors in NY

 

About Mark G Kris

Mark G Kris ( MARK G KRIS ) is An Internal Medicine Physician in New York, NY. The NPI Number for Mark G Kris is 1174594113.
The current location address for Mark G Kris is 1275 YORK AVE New York, NY 10021 and the contact number is and fax number is . The mailing address for Mark G Kris is 633 3RD AVE BOX 3 New York, NY 10017- 6462273813 (mailing address contact number - ).
An internist who specializes in the diagnosis and treatment of all types of cancer and other benign and malignant tumors. This specialist decides on and administers therapy for these malignancies as well as consults with surgeons and radiotherapists on other treatments for cancer.

Provider Business Location on Map

FAQs:

What is the NPI Number for Mark G Kris ?


Answer: The NPI Number for Mark G Kris is 1174594113

Where is Mark G Kris located?


Answer: Mark G Kris is located at 1275 YORK AVE New York, NY 10021.

What is the specialty for Mark G Kris ?


Answer: The Specialty of Mark G Kris is An Internal Medicine Physician.

Are there any online reviews for Mark G Kris ?


Answer: Yes! Check It Now.

Are there any other health care providers in New York, NY?


Answer: Yes, there are given below...

Medicare Physician & Other Practitioners

Information on services and procedures provided to Original Medicare (fee-for-service) Part B (Medical Insurance) beneficiaries by Mark G Kris

Number of HCPCS 6
Number of Medicare Beneficiaries 184
Number of Services 940
Total Submitted Charge Amount 504285
Total Medicare Allowed Amount 108836.73
Total Medicare Payment Amount 83590.29
Total Medicare Standardized Payment Amount 70891.84
Drug Suppress Indicator
Number of HCPCS Associated With Drug Services 0
Number of Medicare Beneficiaries With Drug Services 0
Number of Drug Services 0
Total Drug Submitted Charge Amount 0
Total Drug Medicare Allowed Amount 0
Total Drug Medicare Payment Amount 0
Total Drug Medicare Standardized Payment Amount 0
Medical Suppress Indicator
Number of HCPCS Associated With Medical Services 6
Number of Medicare Beneficiaries With Medical 184
Number of Medical Services 940
Total Medical Submitted Charge Amount 504285
Total Medical Medicare Allowed Amount 108836.73
Total Medical Medicare Payment Amount 83590.29
Total Medical Medicare Standardized Payment Amount 70891.84
Average Age of Beneficiaries 75
Number of Beneficiaries Age Less 65
Number of Beneficiaries Age 65 to 74 84
Number of Beneficiaries Age 75 to 84 74
Number of Beneficiaries Age Greater 84
Number of Female Beneficiaries 123
Number of Male Beneficiaries 61
Number of Non-Hispanic White Beneficiaries 149
Number of Black or African American Beneficiaries
Number of Asian Pacific Islander Beneficiaries 18
Number of Hispanic Beneficiaries
Number of American Indian/Alaska Native Beneficiaries 0
Number of Beneficiaries With Race Not Elsewhere Classified
Number of Beneficiaries With Medicare & Medicaid Entitlement 21
Number of Beneficiaries With Medicare Only Entitlement 163
Percent (%) of Beneficiaries Identified With Atrial Fibrillation 0.13
Percent (%) of Beneficiaries Identified With Alzheimer's Disease or Dementia 0.11
Percent (%) of Beneficiaries Identified With Asthma 0.1
Percent (%) of Beneficiaries Identified With Cancer 0.75
Percent (%) of Beneficiaries Identified With Heart Failure 0.13
Percent (%) of Beneficiaries Identified With Chronic Kidney Disease 0.33
Percent (%) of Beneficiaries Identified With Chronic Obstructive Pulmonary Disease 0.3
Percent (%) of Beneficiaries Identified With Depression 0.26
Percent (%) of Beneficiaries Identified With Diabetes 0.29
Percent (%) of Beneficiaries Identified With Hyperlipidemia 0.65
Percent (%) of Beneficiaries Identified With Hypertension 0.65
Percent (%) of Beneficiaries Identified With Ischemic Heart Disease 0.4
Percent (%) of Beneficiaries Identified With Osteoporosis 0.15
Percent (%) of Beneficiaries Identified With Rheumatoid Arthritis / Osteoarthritis 0.46
Percent (%) of Beneficiaries Identified With Schizophrenia / Other Psychotic Disorders
Percent (%) of Beneficiaries Identified With Stroke 0.09
Average HCC Risk Score of Beneficiaries 2.319

Medicare Part D Prescribers

Information on prescription drugs provided to Medicare beneficiaries enrolled in Part D (Prescription Drug Coverage), by physicians and other health care providers, aggregated by provider.

Provider Specialty Type Medical Oncology
Source of Provider Specialty
Number of Medicare Part D Claims, Including Refills 792
Number of Standardized 30-Day Fills 967.4
Aggregate Cost Paid for All Claims 2737316.66
Number of Day's Supply for All Claims 26255
Number of Medicare Beneficiaries 99
Number of Claims, Including Refills, for Beneficiaries Age 65+ 771
Including Refills, for Beneficiaries Age 65+ 932.4
Beneficiaries Age 65+ 2732037.53
Number of Day's Supply for All Claims for Beneficaries Age 65+ 25270
Number of Medicare Beneficiaries Age 65+
Reason for Suppression of Brnd_Tot_Clms and Brnd_Tot_Drug_Cst
Total Claims of Brand-Name Drugs 254
Reason for Suppression of Gnrc_Tot_Clms and Gnrc_Tot_Drug_Cst
Total Claims of Generic Drugs, Including Refills 538
Aggregate Cost Paid for Generic Drugs 14940.06
Reason for Suppression of Othr_Tot_Clms and Othr_Tot_Drug_Cst
Total Claims of Other Drugs, Including Refills 0
Aggregate Cost Paid for Other Drugs 0
Reason for Suppression of MAPD_Tot_Clmsand MAPD_Tot_Drug_Cst
Number of Claims for Beneficiaries Covered by MAPD Plans 72
Aggregate Cost Paid for Claims Filled by Beneficiaries in MAPD Plans 40645.68
Reason for Suppression of PDP_Tot_Clms and PDP_Tot_Drug_Cst
Number of Claims for Beneficiaries Covered by Standalone PDP Plans 720
Aggregate Cost Paid for Claims Filled by 2696670.98
Reason for Suppression of LIS_Tot_Clms and LIS_Drug_Cst
Number of Claims for Beneficiaries Covered by Low-Income Subsidy 149
Aggregate Cost Paid for Claims Covered by Low-Income Subsidy 695871.45
Reason for Suppression of NonLIS_Tot_Clms and NonLIS_Drug_Cst
Number of Claims for Beneficiaries Not Covered by Low-Income Subsidy 643
by Low-Income Subsidy 2041445.21
Total Claims of Opioid Drugs, Including 45
Aggregate Cost Paid for Opioid Drugs 1911.44
Opioid Claims 19
Opioid_Tot_Clms divided by the Tot_Clms 5.6818181818
Total Claims of Long-Acting Opioid Drugs 16
Aggregate Cost Paid for Long-Acting Opioid 1254.29
Number of Day's Supply of All Long-Acting 465
Long-Acting Opioid Claims
Opioid_LA_Tot_Clms divided by the 35.555555556
Total Claims of Antibiotic Drugs, Including 32
Aggregate Cost Paid for Antibiotic Drugs 629.99
Antibiotic Claims 19
Reason for Suppression of Antpsyct_GE65_Tot_Clms and Antpsyct_GE65_Tot_Drug_Cst
Including Refills, for Beneficiaries Age 65+ 18
Aggregate Cost Paid for AntipsychoticDrugs for Beneficiaries Age 65+ 584.54
Reason for Suppression of Antpsyct_GE65_Tot_Benes
Number of Medicare Beneficiaries Age 65+Filling Antipsychotic Claims
Average Age of Beneficiaries 74.363636364
Number of Beneficiaries Age Less Than 65
Number of Beneficiaries Age 65 to 74
Number of Beneficiaries Age 75 to 84
Number of Female Beneficiaries 66
Number of Male Beneficiaries 33
Number of Non-Hispanic White 77
Number of Black or African American
Number of Asian Pacific Islander
Number of Hispanic Beneficiaries
Number of American Indian/Alaskan NativeBeneficiaries 0
Number of Beneficiaries with Race Not
Only Entitlement 82
Average Hierarchical Condition Category 2.7067320937

More Providers in new-york , ny

mark G kris in Other Directories

Provider don't have other directory link yet.